H-MLLAVLYCL-OH

Rif. 3D-PP47847

Informazioni sul prodotto

• Nome: H-MLLAVLYCL-OH

Descrizione

Peptide H-MLLAVLYCL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-MLLAVLYCL-OH include the following: C. Waca–LFEL T Waca–LFEL, G WOLFF-VORBECK - Symposium in Immunology VI , 2012 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=LtjnCAAAQBAJ&oi=fnd&pg=PR11&dq=(%22MLLAVLYCL%22+OR+%22H-MLLAVLYCL-OH%22)+AND+peptide&ots=mtxlsVorIl&sig=v3hILwWNe3TO_tzuyIUGVeMUvwA Shared and Individual CTL-Defined Antigens on Human Melanoma Cells T Wölfel, J Schneider , M Hauer, C Wölfel - in Immunology VI: Tumor , 1997 - Springerhttps://link.springer.com/content/pdf/10.1007/978-3-642-60562-8.pdf#page=24 Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes T Wölfel, A Van Pel, V Brichard - European journal of , 1994 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830240340 Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanoma NG Chakraborty, JR Sporn, AF Tortora - Cancer Immunology , 1998 - Springerhttps://link.springer.com/article/10.1007/s002620050504 Blood T-cell Vbeta transcriptome in melanoma patients N Degauque , D Schadendorf , S Brouard - journal of cancer, 2004 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.20149 An HLA-A2 polyepitope vaccine for melanoma immunotherapy L Mateo, J Gardner, Q Chen, C Schmidt - The Journal of , 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/163/7/4058/105313 HLA-A2 restricted, melanocyte-specific CD8+ T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against KS Lang, A Muhm, A Moris, S Stevanovic - Journal of Investigative , 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022202X1541262X Multivalent immunity targeting tumor-associated antigens by intra-lymph node DNA-prime, peptide-boost vaccination KA Smith, Z Qiu, R Wong, VL Tam, BL Tam - Cancer Gene , 2011 - nature.comhttps://www.nature.com/articles/cgt201045 Identification of a new shared HLA-A2. 1 restricted epitope from the melanoma antigen tyrosinase JP Riley, SA Rosenberg - Journal of , 2001 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2001/05000/Identification_of_a_New_Shared_HLA_A2_1_Restricted.4.aspx Molecular anatomy of tyrosinase and its related proteins: beyond the histidine-bound metal catalytic center JC Garcaca­a-Borron , F Solano - Pigment Cell Research, 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1034/j.1600-0749.2002.02012.x Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma E Jager, M Ringhoffer - journal of cancer, 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0215(19970410)71:2%3C142::AID-IJC3%3E3.0.CO;2-0 Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: Evidence for immunoselection of antigen-loss E Jager, M Ringhoffer, J Karbach - Journal of Cancer, 1996 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0215(19960516)66:4%3C470::AID-IJC10%3E3.0.CO;2-C Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo E Jager, M Ringhoffer, HP Dienes - journal of cancer, 1996 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0215(19960703)67:1%3C54::AID-IJC11%3E3.0.CO;2-C Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides E Jager, M Maeurer , H Höhn, J Karbach - journal of cancer, 2000 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0215(20000515)86:4%3C538::AID-IJC16%3E3.0.CO;2-G The antigen processing pathway of tyrosinase, a membrane-associated melanoma protein CA Mosse - 2000 - search.proquest.comhttps://search.proquest.com/openview/9b6f30820209004e0deb5ad145369db4/1?pq-origsite=gscholar&cbl=18750&diss=y Transporter (TAP)-and proteasome-independent presentation of a melanoma-associated tyrosinase epitope C Wölfel, I Drexler, A Van Pel, T Thres - journal of cancer, 2000 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1097-0215(20001101)88:3%3C432::AID-IJC16%3E3.0.CO;2-9 Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs). C Ragone, C Manolio, B Cavalluzzo - for ImmunoTherapy of , 2021 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166618/ Immunobiology and immunotherapy of melanoma B Mukherji, NG Chakraborty - Current opinion in oncology, 1995 - journals.lww.comhttps://journals.lww.com/co-oncology/abstract/1995/03000/immunobiology_and_immunotherapy_of_melanoma.14.aspx Peptide Vaccines in Melanoma Patients A Knuth , E Jager - Symposium in Immunology VI: Tumor Immunology, 1997 - Springerhttps://link.springer.com/content/pdf/10.1007/978-3-642-60562-8.pdf#page=133 An antigenic peptide produced by reverse splicing and double asparagine deamidation A Dalet, PF Robbins, V Stroobant - Proceedings of the , 2011 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1101892108 Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2. 1-restricted immune repertoire to melanoma. A Anichini , R Mortarini, C Maccalli - (Baltimore, Md.: 1950 , 1996 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/156/1/208/5646

• Marchio: Biosynth